CBAK Energy Technology Q3 Sales $57.70M Up From $9.56M YoY

CBAK Energy Technology (NASDAQ:CBAT) reported $57.70 million in sales this quarter. This is a 503.43 percent increase over sales of $9.56 million the same period last year.

byBenzinga Newsdesk

November 14, 2022

1 minute read

CBAK Energy Technology (NASDAQ:CBAT) reported $57.70 million in sales this quarter. This is a 503.43 percent increase over sales of $9.56 million the same period last year.

Why Kohl’s Shares Are Surging Today

By Shivani Kumaresan

Today, 1:53 PM

Kohl’s Corp (NYSE:KSS) Board of Directors has entered into exclusive negotiations with Franchise Group Inc (NASDAQ:FRG) over the potential sale. Franchise’s bid of $60…

FRG

CMC Materials Late Wednesday Reported Q3 EPS $1.86 Misses $2.00 Estimate, Sales $309.52M Beat $308.28M Estimate

By Bill Haddad

Today, 1:53 PM

CMC Materials (NASDAQ:CCMP) reported quarterly earnings of $1.86 per share which missed the analyst consensus estimate of $2.00 by 7 percent. This is a 3.33 percent increase over earnings of $1.80 per share from the same

CCMP

Barclays Maintains Overweight on Allegiant Travel, Lowers Price Target to $180

By Benzinga Newsdesk

Today, 1:53 PM

Barclays analyst Brandon Oglenski maintains Allegiant Travel (NASDAQ:ALGT) with a Overweight and lowers the price target from $220 to $180.

ALGT

Pfizer’s COVID-19 Pill Benefited Only Older Adults, New Israel-Based Study Shows

By Vandana Singh

Today, 1:53 PM

According to a new observational study published in the New England Journal of Medicine, Pfizer Inc's (NYSE: PFE) COVID-19 treatment, Paxlovid, only worked among patients 65 years of age or older, with

PFE

CBAK Energy Technology Q3 Sales $57.70M Up From $9.56M YoY

Related Posts

Why Kohl’s Shares Are Surging Today

CMC Materials Late Wednesday Reported Q3 EPS $1.86 Misses $2.00 Estimate, Sales $309.52M Beat $308.28M Estimate

Barclays Maintains Overweight on Allegiant Travel, Lowers Price Target to $180

Pfizer’s COVID-19 Pill Benefited Only Older Adults, New Israel-Based Study Shows